Evaluating the Immunogenicity and Protective Efficacy of a Novel Vaccine Candidate Against Salmonella in Poultry
<b>Background</b>: Non-typhoidal <i>Salmonella</i> (NTS) is a major foodborne pathogen, with poultry products, especially eggs, being the primary source of human infections. Current serovar-specific poultry vaccines effectively reduce targeted <i>Salmonella</i> serovars but may inadvertently promote the emergence of untargeted serovars within poultry flocks. Therefore, novel vaccine candidates providing broad cross-serovar protection are needed to improve overall effectiveness of <i>Salmonella</i> control programs. <b>Objectives</b>: This study evaluated the immunogenicity of the novel subunit vaccine candidate InvG and assessed its ability to reduce <i>Salmonella</i> colonization in vaccinated laying hens and their progeny through maternally derived antibodies transferred via egg yolk. <b>Methodology</b>: Three experiments were performed. Experiment I evaluated the immunogenicity of purified recombinant InvG by (a) measuring anti-InvG antibodies using an enzyme-linked immunosorbent assay (ELISA) and (b) completing transcriptomic profiling of immune responses in vaccinated chickens. Vaccinated chickens were subsequently challenged with <i>Salmonella</i> Enteritidis to assess the efficacy of anti InvG antibodies in reducing intestinal colonization of <i>Salmonella</i>. Experiment II involved immunizing hens with InvG, to evaluate passive transfer of antibodies via egg yolk and the protective efficacy of maternally derived antibodies against <i>Salmonella</i> challenge. Passive transfer was assessed by measuring IgY antibodies in hen serum, egg yolk, and progeny serum, as well as secretory IgA (sIgA) antibodies in progeny intestinal washings using ELISA. Protective efficacy was evaluated by orally challenging one-day-old chicks with three different <i>Salmonella</i> serovars. Experiment III assessed the persistence of anti-InvG antibodies in the serum of vaccinated hens and their transfer into eggs following two doses of InvG. <b>Results</b>: InvG vaccination induced robust IgY antibody responses in hens, with efficient maternal antibody transfer to progeny via egg yolk. A statistically significant reduction in <i>Salmonella</i> colonization was observed in both vaccinated hens and their progeny. <b>Conclusions</b>: These findings demonstrate that InvG represents a promising subunit vaccine candidate for <i>Salmonella</i> control in poultry and warrants further investigation towards development as a broadly protective commercial poultry vaccine against <i>Salmonella</i>.
Authors
- John F. Roberts (ORCID: https://orcid.org/0000-0002-5560-2469)
- Lekshmi K. Edison (ORCID: https://orcid.org/0000-0003-2599-7428)
- Subhashinie Kariyawasam (ORCID: https://orcid.org/0000-0003-2887-7982)
- Roshen N. Neelawala
- Varsha Bommineni (ORCID: https://orcid.org/0009-0007-3866-7520)
- Chaitanya Gottapu
- Krishni K. Gunathilaka
- Gary D. Butcher
Institutions
- Florida Department of Agriculture and Consumer Services (US)
- University of Florida (US)
Publication Details
- Journal
- Vaccines
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3390/vaccines14010068
- Primary Topic
- Salmonella and Campylobacter epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Agriculture
- National Institute of Food and Agriculture